Impact of antihypertensive treatment on quality of life: Comparison between bisoprolol and bendrofluazide

Journal of Human Hypertension

Volumn 13, Issue 8, 1999, Pages 559-563

  Vanmolkot, F H M ^a   De Hoon, J N J M ^a   Van De Ven, L L M ^b   Van Bortel, L M A B ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b E Merck   (Netherlands)

Author keywords

Bendrofluazide; Bisoprolol; Essential hypertension; Quality of life

Indexed keywords

BENDROFLUMETHIAZIDE; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; THIAZIDE DIURETIC AGENT;

ADULT; AGED; ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; ANXIETY; ARTICLE; BORDERLINE HYPERTENSION; CLINICAL TRIAL; COGNITION; CONSTIPATION; CONTROLLED CLINICAL TRIAL; COUGHING; CROSSOVER PROCEDURE; DEPRESSION; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EDEMA; FATIGUE; FEMALE; HEADACHE; HEALTH STATUS; HOSTILITY; HOT FLUSH; HUMAN; LETHARGY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MUSCLE CRAMP; NAUSEA; PHLEBITIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RASH; SYSTOLIC BLOOD PRESSURE; UPPER RESPIRATORY TRACT INFECTION; VERTIGO;

EID: 0032781950     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1000868     Document Type: Article

References (37)

1. Guidelines Sub-Committee. 1993 Guidelines for the management of mild hypertension: memorandum from a World Health Organization/Internatinal Society of hypertension meeting. J Hypertens 1993; 11: 905-918.
2. Wenger NK. Quality of life issues in hypertension: consequences of diagnosis and considerations in management. Am Heart J 1988; 116: 628-632.
3. Bittar N. Maintaining long-term control of blood pressure: the role of improved compliance. Clin Cardiol 1995; 18 (Suppl 3): 12-16.
4. Hjemdahl P, Wiklund IK. Quality of life on antihypertensive drug therapy: scientific endpoint or marketing exercise? J Hypertens 1992; 10: 1437-1446.
5. Croog SH et al. The effects of antihypertensive therapy on the quality of life. N Engl J Med 1986; 14: 1657-1664.
6. Dahlöf C, Dimenäs E, Kendall M, Wiklund I. Quality of life in cardiovascular diseases. Emphasis on β-blocker treatment. Circulation 1991; 84 (Suppl VI): VI-108-VI-118.
7. Steiner SS et al. Antihypertensive therapy and quality of life: a comparison of atenolol, captopril, enalapril and propanolol. J Hum Hypertens 1990; 4: 217-225.
8. Van Bortel LMAB, Ament AJHA. Selective versus non-selective β-adrenoceptor antagonists in hypertension. Pharmacoecon 1995; 8: 513-523.
9. Beto JA, Bansal VK. Quality of life in treatment of hypertension. A metaanalysis of clinical trials. Am J Hypertens 1992; 5: 125-133.
10. Breed JGS et al. Quality of life perception during anti-hypertensive treatment: a comparative study of bisoprolol and enalapril. J Cardiovasc Pharmacol 1992; 20: 750-755.
11. Fletcher AE et al. Quality of life on antihypertensive therapy: a randomized double-blind controlled trial of captopril and atenolol. J Hypertens 1990; 8: 463-466.
12. Fletcher AE et al. Quality of life with three antihypertensive treatments: cilazapril, atenolol, nifedipine. Hypertension 1992; 19: 499-507.
13. Blumenthal JA, Ekelund L-G, Emery CF. Quality of life among hypertensive patients with a diuretic background who are taking atenolol and enalapril. Clin Pharmacol Ther 1990; 48: 447-454.
14. Palmer AJ et al. Quality of life in hypertensives treated with atenolol or captopril: a double-blind crossover trial. J Hypertens 1992; 10: 1409-1416.
15. de Hoon JNJM, Vanmolkot FHM, van de Ven LLM, Van Bortel LMAB. Quality of life comparison between bisoprolol and nifedipine retard in hypertension. Cardiovasc Drugs Ther 1997; 11: 465-471.
16. Dahlöf C et al. The effects of diltiazem and metoprolol on blood pressure, adverse symptoms and general well-being. Eur J Clin Pharmacol 1991; 45: 453-460.
17. Croog SH et al. Hypertensive black men and women. Quality of life and effects of antihypertensive medications. Arch Intern Med 1990; 150: 1733-1741.
18. Paran E, Anson O, Neumann L. The effects of diuretics on quality of life of hypertensive patients. J Hum Hypertens 1996; 10 (Suppl 3): S147-S152.
19. Chang SW et al. The impact of diuretic therapy on reported sexual function. Arch Intern Med 1991; 151: 2402-2408.
20. Wassertheil-Smoller et al. Effect of antihypertensives on sexual function and quality of life: the TAIM study. Ann Intern Med 1991; 114: 613-620.
21. Medical Research Council Working Party. Adverse reactions to bendrofluazide and propanolol for the trearment of mild hypertension. Lancet 1981; ii: 539-543.
22. Croog SH et al. Sexual symptoms in hypertensive patients. A clinical trial of antihypertensive medications. Arch Intern Med 1988; 148: 788-794.
23. Carlsen JE. Relation between dose of bendrofluazide, antihypertensive effect, and adverse biochemical effects. BMJ 1990; 300: 975-978.
24. Applegate WB et al. Impact of the treatment of isolated systolic hypertension on behavioural variables: the SHEP study. Arch Intern Med 1994; 154: 2154-2160.
25. Neaton JD et al. Treatment of Mild Hypertension Study: final results. JAMA 1993; 270: 713-724.
26. Grimm RH Jr et al. Long-term effects on sexual function of five antihypertensive drugs and nutritional-hygienic treatment in hypertensive men and women: Treatment of Mild Hypertension Study (TOMHS). Hypertension 1997; 29: 8-14.
27. Joint National Committee on Prevention D, Evaluation, and Treatment of High Blood Pressure and the National High Blood Pressure Education Program Coordinating Committee. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997; 157: 2413-2446.
28. Bulpitt CJ, Fletcher AE. The measurement of quality of life in hypertensive patients: a practical approach. Br J Clin Pharmac 1990; 30: 353-364.
29. Koch GG. The use of non-parametric methods in the statistical analysis of the two-period change-over design. Biometrics 1972; 28: 577-584.
30. Gillings D, Koch G. The application of the principle of intention-to-treat to the analysis of clinical trials. Drug Inform J 1991; 25 411-424.
31. Testa MA, Simonson DC. Assessment of quality-of-life outcomes. N Eng J Med 1996; 334: 835-840.
32. McCarthy ST, McCarthy GL, John SM, Gould SE. A placebo-controlled cross-over study of ketanserin in elderly hypertensive patients. Cardiovasc Drugs Ther 1990; 4: 115-117.
33. Van Bortel LMAB et al. Nebivolol in hypertension: a double-blind placebo-controlled multicenter study assessing its antihypertensive efficacy and impact on quality of life. J Cardiovasc Pharmacol 1993; 21: 856-862.
34. Boissel JP et al. A randomized comparison of the effect of four antihypertensive monotherapies on the subjective quality of life in previously untreated asymptomatic patients: field trial in general practice. J Hypertens 1995; 13: 1059-1067.
35. Avorn J, Everitt DE, Weiss S. Increased anti-depressant use in patients prescribed beta-blockers. JAMA 1986; 255: 357-360.
36. Starr JM, Whalley LJ, Deary IJ. The effects of antihypertensive treatment on cognitive function. Results from the HOPE Study. J Am Geriatr Soc 1996; 44: 411-415.
37. Westerlund A. Central nervous system side-effects with hydrophilic and lipophilic beta-blockers. Eur J Clin Pharmacol 1985; 28 (Suppl): S73-S76.